{
  "subset": "contraindication",
  "disease": "Neurotransmitter disorders",
  "relation": "contraindication",
  "gold_drugs": [
    "(2r + 6r)-hydroxynorketamine (0.25 to + kg)",
    "[68ga]rm2",
    "active aprepitant",
    "aph-1501",
    "aripiprazole",
    "aripiprazole + escitalopram",
    "aripiprazole + escitalopram + omega-3 pufas",
    "bnc",
    "clonidine",
    "comparator",
    "cx516",
    "day + sodium benzoate 2gram",
    "deltoid + ly03010 treatment group",
    "desloratadine",
    "detemir",
    "dextroamphetamine",
    "diltiazem",
    "doxazosin",
    "duloxetine",
    "escitalopram",
    "escitalopram + omega-3 pufas",
    "gluteal + ly03010 treatment group",
    "guanfacine extended release",
    "icatibant ()",
    "intravenous ketamine",
    "invega sustenna",
    "ketamine",
    "ketorolac oral tablet",
    "kuvantm therapy",
    "latanoprost 0.005% ophthalmic solution",
    "lidocaine infusion",
    "lidocaine-ketamine infusion",
    "lidocaine-magnesium infusion",
    "lithium",
    "ly03005",
    "ly03010; paliperidone palmitate",
    "mdma",
    "methamphetamine",
    "methylphenidate",
    "metoprolol",
    "metoprolol xl",
    "midazolam",
    "modafinil + pet",
    "morphine",
    "nebivolol",
    "nebulized ketamine",
    "omeprazole capsule",
    "placebo aprepitant",
    "placebo oral capsule",
    "posiphen",
    "pregabalin",
    "pristiq",
    "ropinirole implant",
    "ropinirole oral product",
    "sapropterin dihydrochloride",
    "sgs-742",
    "ticagrelor",
    "timolol 0.5% ophthalmic solution",
    "tizanidine",
    "vts-k"
  ],
  "seeds_initial": [
    "Dopamine",
    "Glutamate",
    "Norepinephrine",
    "Serotonin",
    "Bupropion",
    "Phenelzine",
    "Tramadol",
    "Citalopram",
    "Fluoxetine",
    "Venlafaxine",
    "Amphetamines",
    "Atomoxetine"
  ],
  "seed_history": [
    [
      "Dopamine",
      "Glutamate",
      "Norepinephrine",
      "Serotonin",
      "Bupropion",
      "Phenelzine",
      "Tramadol",
      "Citalopram",
      "Fluoxetine",
      "Venlafaxine",
      "Amphetamines",
      "Atomoxetine"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_dopamine",
          "name": "Dopamine"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Dopamine可能导致不良反应",
          "证据支持Dopamine引发神经递质失调"
        ],
        "caveats": [
          "安全性和有效性亟待进一步验证"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_glutamate",
          "name": "Glutamate"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Glutamate在神经递质失调中发挥作用",
          "可能存在不良反应影响药效"
        ],
        "caveats": [
          "需更多数据支持其安全性与有效性"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_norepinephrine",
          "name": "Norepinephrine"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "去甲肾上腺素可能导致神经递质失调",
          "潜在风险可能影响疗效"
        ],
        "caveats": [
          "需进一步确认其安全性"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_serotonin",
          "name": "Serotonin"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H4_round4",
        "key_assumptions": [
          "Serotonin可能引发神经递质失调",
          "可能的不良反应影响效果"
        ],
        "caveats": [
          "缺乏足够证据验证"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_bupropion",
          "name": "Bupropion"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H5_round4",
        "key_assumptions": [
          "Bupropion可能帮助神经递质平衡",
          "潜在风险可能减弱疗效"
        ],
        "caveats": [
          "需验证其安全性"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H6",
        "candidate": {
          "id": "drug_phenelzine",
          "name": "Phenelzine"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H6_round4",
        "key_assumptions": [
          "Phenelzine可能影响神经递质路径",
          "潜在的不良反应"
        ],
        "caveats": [
          "需要更多研究支持"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H7",
        "candidate": {
          "id": "drug_tramadol",
          "name": "Tramadol"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H7_round4",
        "key_assumptions": [
          "Tramadol与神经递质失调相关",
          "潜在影响假设的有效性"
        ],
        "caveats": [
          "安全性亟需进一步验证"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H8",
        "candidate": {
          "id": "drug_citalopram",
          "name": "Citalopram"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H8_round4",
        "key_assumptions": [
          "Citalopram可能影响神经递质",
          "潜在的负面影响"
        ],
        "caveats": [
          "需增加安全性验证"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H9",
        "candidate": {
          "id": "drug_fluoxetine",
          "name": "Fluoxetine"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H9_round4",
        "key_assumptions": [
          "Fluoxetine对神经递质有潜在影响",
          "可能的副作用"
        ],
        "caveats": [
          "需更多证据支持"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H10",
        "candidate": {
          "id": "drug_venlafaxine",
          "name": "Venlafaxine"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H10_round4",
        "key_assumptions": [
          "Venlafaxine可能影响神经递质",
          "存在不良反应风险"
        ],
        "caveats": [
          "安全性需进一步验证"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H11",
        "candidate": {
          "id": "drug_amphetamines",
          "name": "Amphetamines"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H11_round4",
        "key_assumptions": [
          "Amphetamines对神经递质失调有影响",
          "可能产生显著不良反应"
        ],
        "caveats": [
          "需要更多验证"
        ],
        "confidence": "low"
      },
      {
        "hypothesis_id": "H12",
        "candidate": {
          "id": "drug_atomoxetine",
          "name": "Atomoxetine"
        },
        "score": 0.1,
        "graph_snapshot_ref": "GE_H12_round4",
        "key_assumptions": [
          "Atomoxetine可能与神经递质失调相关",
          "潜在风险可能影响效果"
        ],
        "caveats": [
          "需进一步确认"
        ],
        "confidence": "low"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "风险路径关联至各药物",
          "reason": "多条通路与不良效应的联系未消解"
        }
      ],
      "remaining_gaps": [
        "缺乏更明确的安全性及有效性说明"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that are contraindicated or could worsen the rare disease 'Neurotransmitter disorders'. Return only names.\n\n# Heuristics:\n- When 针对神经传导障碍的药物开发: then 必须识别潜在副作用，尤其是影响心理健康的风险。\n- When 设计针对神经传递机制的干预: then 需考虑药物之间可能的交互作用及其机制合理性。"
}